Home General Biotechnology Journal of Commercial Biotechnology — January 2010 issue now available

Journal of Commercial Biotechnology — January 2010 issue now available

The January 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 16, Issue 1

Editorial

Time for a new business model?PDF
Yali Friedman

Commentary

Why data exclusivity is the new patent protectionPDF
Peter J Pitts
Follow-on biologic drug competition – No need for new marketing exclusivitiesPDF
Michael S Wroblewski, Elizabeth A Jex

Articles

Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumbPDF
Nigel Borshell, Adrian Dawkes
Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firmsPDF
Mark J Ahn, Michael Meeks, Sally Davenport, Rebecca Bednarek
Intellectual property landscape and patenting opportunity in biofuelsPDF
Ramasamy Mannan
Challenges and opportunities in the licensing of renewable technologiesPDF
Meredith Lloyd-Evans, Mike Gilbert, Ilian P Iliev
Ethiopia: Biotechnology for developmentPDF
Desta Berhe Sbhatu
Innovation and commercialisation in the stem cell industries in Australia: State strategies and other opportunities to build a competitive position in the global stem cell economyPDF
Olivia Harvey

Legal and Regulatory Updates

Using IP audits to optimize IP assetsPDF
James G Cullem

Book Reviews

Book Review: Health-care investing: Profiting from the new world of pharma, biotech and health-care servicesPDF
Frank LaSaracina
Book Review: Aging, Biotechnology, and the FuturePDF
Harley King

1 COMMENT

Leave a Reply